Vanta Bioscience Limited (BOM:540729)
19.89
0.00 (0.00%)
At close: Feb 9, 2026
Vanta Bioscience Revenue
Vanta Bioscience had revenue of 3.02M INR in the half year ending September 30, 2025, a decrease of -95.14%. This brings the company's revenue in the last twelve months to 12.35M, down -73.02% year-over-year. In the fiscal year ending March 31, 2025, Vanta Bioscience had annual revenue of 19.64M, down -79.80%.
Revenue (ttm)
12.35M
Revenue Growth
-73.02%
P/S Ratio
10.17
Revenue / Employee
343.01K
Employees
36
Market Cap
125.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.64M | -77.59M | -79.80% |
| Mar 31, 2024 | 97.23M | 34.47M | 54.92% |
| Mar 31, 2023 | 62.76M | -37.42M | -37.36% |
| Mar 31, 2022 | 100.18M | -331.32K | -0.33% |
| Mar 31, 2021 | 100.51M | -40.93M | -28.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Compuage Infocom | 249.31M |
| Cian Healthcare | 232.80M |
| Shangar Décor | 170.10M |
| Laddu Gopal Online Services | 132.10M |
| New Light Industries | 92.51M |
| Colinz Laboratories | 58.40M |
| Beryl Securities | 25.40M |
| Ontic Finserve | 9.62M |